Leadership

A seasoned intellectual property (IP) professional with 20 years of experience, Björn excels in creating, establishing, and managing trademark and licensing concepts. His proven track record includes successfully managing trademarks and licenses for a leading Swiss company across over 50 jurisdictions. Björn brings a deep understanding of brand valuation and brand equity measurements to the table, having played a pivotal role in supporting big-four-teams to establish IP management and licensing structures for multinational companies.  Björn currently offers leadership advisory services for global consumer and industrial brands and is actively involved in thought-leading brand and trademark management networks.

Marc is a versatile professional with extensive experience in intellectual property (IP) management, marketing, and international business. He has a proven track record of success in managing a portfolio of 14,000 clients as a former Executive Committee Member of a multinational IP Advisory Firm.

Marc's background also includes being an MBA Professor of Marketing and Latin American Studies.  He has experience leading a Global Business Unit in the building materials industry and served on the board of an NGO focused on affordable housing. This well-rounded experience allows Marc to bring a unique perspective to their work.

Camilo possesses a Master of Science in Development Economics with a focus on technological advancement and its economic impact. He boasts over 15 years of experience in innovation, project management, and financial valuation/structuring across various sectors and company types, including intangible assets.

His background includes extensive experience in assessing, evaluating, and administering highly innovative projects, corporate entrepreneurship initiatives, and projects focused on corporate finance and/or strategic growth. Furthermore, Camilo is a specialist in managing and valuing intangible assets, particularly in the healthcare, finance, IT/Software, hospitality, and pharmaceutical industries.